| Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists LA Solt, Y Wang, S Banerjee, T Hughes, DJ Kojetin, T Lundasen, Y Shin, ... Nature 485 (7396), 62-68, 2012 | 777 | 2012 |
| REV-ERB and ROR nuclear receptors as drug targets DJ Kojetin, TP Burris Nature reviews Drug discovery 13 (3), 197-216, 2014 | 534 | 2014 |
| Nuclear receptors and their selective pharmacologic modulators TP Burris, LA Solt, Y Wang, C Crumbley, S Banerjee, K Griffett, ... Pharmacological reviews 65 (2), 710-778, 2013 | 285 | 2013 |
| DNA binding alters coactivator interaction surfaces of the intact VDR–RXR complex J Zhang, MJ Chalmers, KR Stayrook, LL Burris, Y Wang, SA Busby, ... Nature structural & molecular biology 18 (5), 556-563, 2011 | 226 | 2011 |
| An alternate binding site for PPARγ ligands TS Hughes, PK Giri, IMS De Vera, DP Marciano, DS Kuruvilla, Y Shin, ... Nature communications 5 (1), 3571, 2014 | 182 | 2014 |
| The REV-ERBs and RORs: molecular links between circadian rhythms and lipid homeostasis LA Solt, DJ Kojetin, TP Burris Future medicinal chemistry 3 (5), 623-638, 2011 | 179 | 2011 |
| Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERB D Kojetin, Y Wang, TM Kamenecka, TP Burris ACS chemical biology 6 (2), 131-134, 2011 | 174 | 2011 |
| Characterization of the core mammalian clock component, NPAS2, as a REV-ERBα/RORα target gene C Crumbley, Y Wang, DJ Kojetin, TP Burris Journal of Biological Chemistry 285 (46), 35386-35392, 2010 | 171 | 2010 |
| Ligand and receptor dynamics contribute to the mechanism of graded PPARγ agonism TS Hughes, MJ Chalmers, S Novick, DS Kuruvilla, MR Chang, ... Structure 20 (1), 139-150, 2012 | 169 | 2012 |
| Resveratrol modulates the inflammatory response via an estrogen receptor-signal integration network JC Nwachukwu, S Srinivasan, NE Bruno, AA Parent, TS Hughes, ... elife 3, e02057, 2014 | 142 | 2014 |
| Structural mechanism for signal transduction in RXR nuclear receptor heterodimers DJ Kojetin, E Matta-Camacho, TS Hughes, S Srinivasan, JC Nwachukwu, ... Nature communications 6 (1), 8013, 2015 | 132 | 2015 |
| Small molecule modulation of nuclear receptor conformational dynamics: implications for function and drug discovery DJ Kojetin, TP Burris Molecular pharmacology 83 (1), 1-8, 2013 | 131 | 2013 |
| Conserved sequence-specific lincRNA–steroid receptor interactions drive transcriptional repression and direct cell fate WH Hudson, MR Pickard, IMS De Vera, EG Kuiper, ... Nature communications 5 (1), 5395, 2014 | 123 | 2014 |
| Identification of SR3335 (ML-176): a synthetic RORα selective inverse agonist N Kumar, DJ Kojetin, LA Solt, KG Kumar, P Nuhant, DR Duckett, ... ACS chemical biology 6 (3), 218-222, 2011 | 123 | 2011 |
| Pharmacological repression of PPARγ promotes osteogenesis DP Marciano, DS Kuruvilla, SV Boregowda, A Asteian, TS Hughes, ... Nature communications 6 (1), 7443, 2015 | 118 | 2015 |
| Ebselen, a small-molecule capsid inhibitor of HIV-1 replication S Thenin-Houssier, IMS De Vera, L Pedro-Rosa, A Brady, A Richard, ... Antimicrobial agents and chemotherapy 60 (4), 2195-2208, 2016 | 111 | 2016 |
| Structure, binding interface and hydrophobic transitions of Ca2+-loaded calbindin-D28K DJ Kojetin, RA Venters, DR Kordys, RJ Thompson, R Kumar, J Cavanagh Nature structural & molecular biology 13 (7), 641-647, 2006 | 110 | 2006 |
| Cryptic glucocorticoid receptor-binding sites pervade genomic NF-κB response elements WH Hudson, IMS Vera, JC Nwachukwu, ER Weikum, AG Herbst, Q Yang, ... Nature communications 9 (1), 1337, 2018 | 107 | 2018 |
| PGRMC2 is an intracellular haem chaperone critical for adipocyte function A Galmozzi, BP Kok, AS Kim, JR Montenegro-Burke, JY Lee, R Spreafico, ... Nature 576 (7785), 138-142, 2019 | 95 | 2019 |
| REV-ERBα regulates TH17 cell development and autoimmunity M Amir, S Chaudhari, R Wang, S Campbell, SA Mosure, LB Chopp, Q Lu, ... Cell reports 25 (13), 3733-3749. e8, 2018 | 89 | 2018 |
